Patricia Andrews

Currently holds a position at Crescent Biopharma Inc

0.5

0.5

Position	Company	Period
Independent Director	Crescent Biopharma Inc	June 12, 2017 -
Executive Vice President, Chief Commercial Officer	Incyte Corp	Oct. 20, 2008 - Aug. 29, 2012

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Oncolytics Biotech Inc (ONC)

Transaction date 12 Feb 2026

Purchase

Price

201.95

Quantity 69,815 +4.3%

Value US$818,925

Comments Filing

Crescent Biopharma Inc (CBIO)

Transaction date 16 Nov 2021

Purchase

Price

87.80

Quantity 11,529 +8.7%

Value US$2,466,659

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-02-13	2026-02-12	Oncolytics Biotech Inc (ONC)	B Purchase	69,815 +4.3% 201.95 US$818,925	69,815 +4.3%	201.95	US$818,925
2021-11-18	2021-11-16	Crescent Biopharma Inc (CBIO)	B Purchase	11,529 +8.7% 87.80 US$2,466,659	11,529 +8.7%	87.80	US$2,466,659